GANGLIOSIDE GM-1 ANTIBODIES IgG and IgM Test
At DNA Labs UAE, we offer the GANGLIOSIDE GM-1 ANTIBODIES IgG and IgM Test to help diagnose and monitor autoimmune disorders affecting the nervous system. This blood test measures the levels of IgG and IgM antibodies against ganglioside GM-1, which are glycosphingolipids found on the surface of nerve cells.
Test Details
The GANGLIOSIDE GM-1 ANTIBODIES IgG & IgM test is used to detect the presence of antibodies against ganglioside GM-1 in the blood. Elevated levels of IgG and/or IgM antibodies may indicate an autoimmune response targeting the peripheral nerves. However, it is important to note that a positive result does not confirm a specific diagnosis and further evaluation is usually required.
Symptoms and Diagnosis
This test is particularly useful in diagnosing and monitoring autoimmune disorders such as Guillain-Barr syndrome and other peripheral neuropathies. Common symptoms of these disorders include muscle weakness, numbness, tingling, and difficulty with coordination. If you are experiencing these symptoms, it is recommended to consult a neurologist for further evaluation.
Test Cost
The cost of the GANGLIOSIDE GM-1 ANTIBODIES IgG and IgM Test is AED 3300.0.
Sample Condition
A minimum of 2 mL of serum from 1 SST is required for the test. The sample should be shipped refrigerated or frozen. Overnight fasting is preferred. Additionally, a duly filled Test Send Out Consent Form is mandatory.
Report Delivery
The sample should be sent by the 7th of the month, and the report will be delivered after 2-3 weeks.
Method
The GANGLIOSIDE GM-1 ANTIBODIES IgG and IgM Test is performed using an immunoassay method.
Doctor and Test Department
This test is usually ordered by a neurologist and falls under the Disorders of Nervous System category. The test department responsible for conducting this test is OS.
Pre Test Information
It is recommended to fast overnight before taking the test. Additionally, a duly filled Test Send Out Consent Form is mandatory.
Interpretation of Results
The results of the GANGLIOSIDE GM-1 ANTIBODIES IgG and IgM Test are reported as a numerical value indicating the level of antibodies present in the blood. A healthcare provider, usually a neurologist, will interpret the results based on the individual’s symptoms and medical history to determine their significance.
For more information or to schedule a GANGLIOSIDE GM-1 ANTIBODIES IgG and IgM Test, please contact DNA Labs UAE.
Test Name | GANGLIOSIDE GM-1 ANTIBODIES IgG and IgM Test |
---|---|
Components | |
Price | 3300.0 AED |
Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is preferred. Duly filled Test Send Out Consent Formis mandatory. |
Report Delivery | Sample by 7th of the month; Report after 2??3 weeks. |
Method | Immunoassay |
Test type | Disorders of Nervous System |
Doctor | Neurologist |
Test Department: | OS |
Pre Test Information | Overnight fasting is preferred. Duly filled Test Send Out Consent Formis mandatory. |
Test Details |
The GANGLIOSIDE GM-1 ANTIBODIES IgG & IgM test is a blood test that measures the levels of IgG and IgM antibodies against ganglioside GM-1 in the blood. Gangliosides are a type of glycosphingolipids found on the surface of nerve cells. Antibodies against ganglioside GM-1 can be produced in certain autoimmune disorders, such as Guillain-Barr syndrome and other peripheral neuropathies. This test is used to help diagnose and monitor these autoimmune disorders. Elevated levels of IgG and/or IgM antibodies against ganglioside GM-1 may indicate an autoimmune response targeting the peripheral nerves. However, it is important to note that a positive result does not necessarily confirm a specific diagnosis and further evaluation is usually required. The test involves taking a blood sample, which is then sent to a laboratory for analysis. The results are typically reported as a numerical value indicating the level of antibodies present in the blood. A healthcare provider will interpret the results and determine the significance based on the individual’s symptoms and medical history. |